Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
miglustat
Ultragenyx UK Limited
GM1 Gangliosidoses
1 trial -
oral entecavir 0.5mg daily and adefovir 10mg daily for 144 weeks
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Hepatitis B
1 trial -
rhPTH (1-84)
Takeda
Hypoparathyroidism
3 trials -
rhPTH(1-84)
Takeda
Chronic Hypoparathyroidism
2 trials -
split-virion, adjuvanted H1N1 vaccine of 7.5 ΞΌg per dose
Sinovac Research and Development Co.,
Influenza
1 trial -
tiotropium 18 mcg
Boehringer Ingelheim
Pulmonary Disease, Chronic Obstructive
1 trial -
0.01% concentration atropine drops
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acupressure
1 trial -
0.1% bromfenac ophthalmic solution
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cataract
1 trial -
1.23% fluoride foam application
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Dental Caries in Children
1 trial -
10% N2O
BRIGHT MINDS BIOSCIENCES INC.
Opioid-Related Disorders
1 trial -
100mg aspirin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Recurrent Acute Pancreatitis
1 trial -
100mg diclofenac
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Post-ERCP Acute Pancreatitis
1 trial -
11UCB-J PET Scan
BRIGHT MINDS BIOSCIENCES INC.
Opiate Dependence
1 trial -
18F-FDG
The First People's Hospital of Lianyungang
Tumor, Solid
1 trial -
18F-P3BZA
Xijing Hospital
Melanoma
1 trial -
18F-PMPBB3 (APN-1607) PET imaging
Hospital Authority, Hong Kong
Tau Distributions in Patients With Tauopathy Using APN-1607 PET Scan
1 trial -
18F-PSMA-1007
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Multiple Myeloma
1 trial -
A continuous intravenous infusion of 0.5-0.6 mg/kg/h Rocuronium Bromide Intravenous Solution (50 Mg/5 mL) to keep the target neuromuscular blockade (PTC = 1-2).
The First People's Hospital of Lianyungang
Neuromuscular Blockade
1 trial -
ASC09/ritonavir group
The First People's Hospital of Lianyungang
2019-nCoV
1 trial -
Anti-BCMA and CD19 CART cells will be injected intravenously on a one-time basis.
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Autoimmune Diseases
1 trial -
Anti-PD1
Hospital Authority, Hong Kong
Nasopharyngeal Carcinoma (NPC)
1 trial -
Astaxanthin (2mg)+Lycopene (1.8mg)+D-Alpha-Tocopherol (10IU)
United Therapeutics Europe Ltd
Skin Aging
1 trial -
BRL-101
The First People's Hospital of Lianyungang
Sickle Cell Disease
1 trial -
Bundle Group 1 with Nutrilite Lifestyle
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Osteoarthritis
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources